| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/30/2006 | CN1824025A Medicine and frod dual purpose nutrient composed of Chinese and western medicine for preventing frue myopia and its manufacturing method |
| 08/30/2006 | CN1823970A Medicine and food dual purpose Chinese medicinal product for preventing and treating red eye, aversion to light and its manufacturing method |
| 08/30/2006 | CN1823969A Medicine and food dual purpose Chinese medicinal product for preventing and treating red eye, swell pain and its manufacturing method |
| 08/30/2006 | CN1823968A Medicine and food dual purpose Chinese medicinal product for preventing and treating red eye, aversion to light, swell pain and its manufacturing method |
| 08/30/2006 | CN1823840A Medicine and food dual purpose nutritive product for preventing and treating nightblindness and its manufacturing method |
| 08/30/2006 | CN1823839A Vitamin microelement mineral calcium nutritire product for preventing and treating nightblindness and its manufacturing method |
| 08/30/2006 | CN1823838A Medicine and food dual purpose vitamin micro element mineral calcium nutritive product for preventing myopia and its manufacturing method |
| 08/30/2006 | CN1823837A Western medicien and food dual purpose nutritire product for preventing and treating myopia and its manufacturing method |
| 08/30/2006 | CN1823836A Medicine and food dual purpose nutritive product for preventing and treating pseudomyopia and its manufacturing method |
| 08/30/2006 | CN1823835A Compound vitamin microelement mineral nutritive product for preventing and treating pseudomyopia and its manufacturing method |
| 08/30/2006 | CN1823834A Medicine and food dual purpose compound vitamin microelement mineral nutritive product for preventing true myopia and its manufacturing method |
| 08/30/2006 | CN1823833A Medicine and food dual purpose product for preventing true myopia and its manufacturing method |
| 08/30/2006 | CN1823832A Medicine and fool dual purpose vitamin microelement nutritive product for preventing ane treating cataract and its manufacturing method |
| 08/30/2006 | CN1823831A Medicine and food dual purpose nutritive product for preventing and treating cataract and its manufacturing method |
| 08/30/2006 | CN1823830A Medicine and food dual purpose nutritive product for preventing pseudomyopia and real myopia and its manufacturing method |
| 08/30/2006 | CN1823829A Vitamin micro element mineral calcium nutritive product for preventing pseudomyopia and roal myopia and its manufacturing method |
| 08/30/2006 | CN1823828A Medicine and frod dual purpose compound vitamin and compound microelement nutritive product for preventing and treating xeroma and its manufacturing method |
| 08/30/2006 | CN1823827A Medicine and food dual purpose nutritive product for preventing and treating xeroma and its manufacturing method |
| 08/30/2006 | CN1823826A Medicine and food dual purpose nutritive product for preventing and treating keratomalacid and its manufacturing method |
| 08/30/2006 | CN1823825A Medicine and food vitamin and microelement nutritive product for preventing and treating keratomalacia and its manufacturing method |
| 08/30/2006 | CN1823824A Medicine and food dual purpose nutritive product for preventing and treating synchysis and its manufacturing method |
| 08/30/2006 | CN1823823A medicine and food dual purpose vitamin microelement nutritive product for preventing and treating synchysis and its manufacturing method |
| 08/30/2006 | CN1823822A Food and medicien nutritive element for preventing and treating vision syndrome due to computer and its manufacturing method |
| 08/30/2006 | CN1823821A Vitamin and microelements nutritive product for preventing and treating vision syndrome due to computer and its manufacturing method |
| 08/30/2006 | CN1823820A Vitamin and micro element product for prevonting and treating vision injury syndrome due to TV and computer display light and its manufacturing method |
| 08/30/2006 | CN1823819A Food and medicine dual purpose product for preventing and treating vision injury syndrome duo to TV and computer display light and its manufacturing method |
| 08/30/2006 | CN1823797A Compound eye drops for treating electro-optic harmed eye |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823772A New pranoprofen eye drops and its preparation method |
| 08/30/2006 | CN1823758A Compounds and methods of treating transplant rejection |
| 08/30/2006 | CN1823754A Sodium bromophenolate eye drops and its preparation method |
| 08/30/2006 | CN1272334C Quinuclidine derivs. as muscarinic M3 receptors ligand and their use |
| 08/30/2006 | CN1271998C An anti-cataract medicine |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | CA2402020C Pharmaceutical compositions |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1 |
| 08/24/2006 | WO2006087968A1 Solid ophthalmic drug for external use |
| 08/24/2006 | WO2006065746A3 Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations |
| 08/24/2006 | WO2006061156A3 Medicament for hygienic application inside the ear |
| 08/24/2006 | WO2006056823A8 Modulating retinal pigmented epithelium permeation by inhibiting or activating vegfr-1 |
| 08/24/2006 | WO2005102303A3 Antiprostaglandins for the treatment of ocular pathologies |
| 08/24/2006 | US20060191024 Method for preparing anti-MIF antibodies |
| 08/24/2006 | US20060189673 Phenylazole compound, production process therefor and antioxidant |
| 08/24/2006 | US20060189669 Pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189597 Lactam compounds and pharmaceutical use thereof |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060189541 Methods of treating dry eye disorders |
| 08/24/2006 | US20060188576 Pirenzepine ophthalmic gel |
| 08/24/2006 | US20060188560 Delivery system for nucleic acids |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | CA2597525A1 Solid ophthalmic drug for external use |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693367A1 Piperidine compound and method for producing same |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693060A1 Therapeutic or preventive agents for ischemic neuropathy |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1691815A1 Superoxide dismutase mimics for the treatment of optic nerve and retinal damage |
| 08/23/2006 | EP1691798A1 Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions |
| 08/23/2006 | EP1485084B9 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1385528B1 Disinfecting and solubilizing steroid compositions |
| 08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
| 08/23/2006 | EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1212058B1 Topical treatment for prevention of ocular infections |
| 08/23/2006 | EP1198232B1 Urea substituted imidazoquinolines |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | EP0914827B1 Ophthalmic drug compositions |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/23/2006 | CN1270707C Ophthalmic solution |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094761 A GPCR-like protein for treating glaucoma |
| 08/22/2006 | US7094552 Diagnostic test kits |
| 08/17/2006 | WO2006085687A1 Composition containing dihomo-ϝ-linolenic acid (dgla) as the active ingredient |
| 08/17/2006 | WO2006084687A1 Use of zeaxanthin for the treatment of diseases of the peripheral retina |
| 08/17/2006 | WO2006059357A9 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/ or reversing ocular diseases related with ocular neovascularization |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III |
| 08/17/2006 | US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors |
| 08/17/2006 | CA2599112A1 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
| 08/16/2006 | EP1690857A1 Modified-protein formation inhibitor |
| 08/16/2006 | EP1689397A2 Amelioration of macular degeneration and other ophthalmic diseases |
| 08/16/2006 | EP1689396A1 Prevention and/or reduction of photoreceptor degeneration with retinoids |